Kwality Pharmaceuticals (NSE:KPL) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KPL Kwality Pharmaceuticals Ltd NSE:KPL
60 GF Score
Price ₹3,630.30
GF Value ₹1,332.01
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kwality Pharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

NSE:KPL
60GF Score
Kwality Pharmaceuticals Ltd NSE:KPL
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kwality Pharmaceuticals (NSE:KPL) Overvalued in 2026?

Based on GuruFocus' analysis, Kwality Pharmaceuticals stock appears to be overvalued. The current stock price of ₹3,630.30 is trading 172.5% above its estimated GF Value™ of ₹1,332.01. GuruFocus considers Kwality Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:KPL:

  • FFO per Share:
  • GF Value™: ₹1,332.01 vs. price of ₹3,630.30 (172.5% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the NSE:KPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kwality Pharmaceuticals Business Description

Comparable Companies
Other Exchanges 539997:India
Address Majitha Road, Village Nagkalan, 6th Mile Stone, Amritsar, PB, IND, 143601
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.
60GF Score

Get the complete analysis for NSE:KPL

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,630.30
Price
₹1,332.01
GF Value